CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 85 filers reported holding CTI BIOPHARMA CORP in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $14,000 | -58.8% | 26,979 | 0.0% | 0.00% | – |
| Q4 2015 | $34,000 | -12.8% | 26,979 | 0.0% | 0.00% | – |
| Q3 2015 | $39,000 | -26.4% | 26,979 | 0.0% | 0.00% | – |
| Q2 2015 | $53,000 | +3.9% | 26,979 | 0.0% | 0.00% | – |
| Q1 2015 | $51,000 | -20.3% | 26,979 | 0.0% | 0.00% | – |
| Q4 2014 | $64,000 | -4.5% | 26,979 | 0.0% | 0.00% | – |
| Q3 2014 | $67,000 | – | 26,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 10,698,618 | $13,159,000 | 15.42% |
| BVF INC/IL | 43,795,613 | $53,869,000 | 9.18% |
| DAFNA Capital Management LLC | 3,195,381 | $3,930,000 | 3.50% |
| Sio Capital Management, LLC | 5,292,262 | $6,509,000 | 2.88% |
| NEXTHERA CAPITAL LP | 656,000 | $807,000 | 1.14% |
| Lombard Odier Asset Management (USA) Corp | 1,357,456 | $1,670,000 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,236,832 | $2,751,000 | 0.11% |
| Consonance Capital Management LP | 510,000 | $635,000 | 0.08% |
| Candriam S.C.A. | 1,515,000 | $1,863,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 575,669 | $708,000 | 0.04% |